Skip to main content

Advertisement

SpringerLink
Log in

Marginal effects of regional intra-arterial chemotherapy as an alternative treatment option in advanced pancreatic carcinoma

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Locoregional intra-arterial (i.a.) chemotherapy may provide high levels of cytostatic concentrations within the tumour and, simultaneously, a low rate of systemic side effects compared with systemic administration of anti-neoplastic drugs. In addition, this may lead to an increase of tumour response rate and prolongation of survival time. The aim of the study was (1) to evaluate the benefit of an i.a. infusion of cytostatic drugs via the coeliac trunk on tumour response rate and survival time, (2) to elucidate problems and risks, and finally (3) to achieve an improvement of overall therapeutic management in pancreatic carcinoma.

Patients and methods

In 22 patients (12 female; 10 male; mean age 57.1 years) with locally advanced pancreatic carcinoma, which was confirmed by histopathology, i.a. chemotherapy was administered. Through a catheter, which was inserted via the femoral artery by the Seldinger technique and placed with the tip in the coeliac trunk, two different drug combinations were given. Group A (n=12) were given a bolus injection of a mixture (chemo-occlusion) consisting of amilomer (Spherex) and epirubicin (Farmorubicin) followed by short-time infusion of folic acid and 24-h infusion of 5-FU. Group B (n=10) were given treatment over 5 days: mitoxantrone (Novantrone, day [d] 1), 5-FU and folic acid (Haemato-folin, d 2–4), and cisplatin (d 5). Treatment was repeated in both groups every 4 weeks. Tumour response was assessed by computed tomography every 8 weeks.

Results

In group A, there was one complete and one partial remission, resulting in a remission rate of 16.6%. Two patients showed stable disease, while in two-thirds of the patients (n=8), progressive disease was found. Median survival time was 3 months; 1-year survival rate was 33.3% (4 of 12 patients). In group B, again, one complete and one partial remission were observed (remission rate 20%). In three cases, stable disease, and in 50% of patients (n=5), progressive disease, were documented. Median survival was 7.0 months; 1-year survival rate was 20% (2 of 10 patients). If both groups were compared, there was no difference in survival. In addition, no prolongation of survival time was found in comparison with patients of a historical study group treated with established systemic chemotherapy using gemcitabine monotherapy (n=28; median survival time 9 months). Though a tendency for poorer outcome of i.a. chemotherapy was seen when the Kaplan–Meier curves of survival were compared, this difference was not statistically significant (log rank test, P=0.08).

Conclusion

Despite conceptual and pharmacokinetic advantages of locoregional i.a. chemotherapy, better outcome with regard to tumour response rate and survival time could not be found. I.a. chemotherapy is, therefore, still an experimental treatment option in pancreatic carcinoma and can, currently, not be recommended for routine use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Matthias M, Wolff H (1987) Problems of antineoplastic chemotherapy of pancreatic cancer. Zentralbl Chir 112:1322–1336

    PubMed  Google Scholar 

  2. Collins JM (1984) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498–504

    CAS  PubMed  Google Scholar 

  3. Schalhorn A, Kuhl M (1995) Pharmacology of regional chemotherapy of colorectal liver metastases. Zentralbl Chir 120:764–768

    PubMed  Google Scholar 

  4. Meta-Analysis Group (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252–258

    PubMed  Google Scholar 

  5. Aigner KR, Santinami M (1994) Regional therapy for pelvic, rectal and urologic tumors: has it any role? Reg Cancer Treat 1:1

    Google Scholar 

  6. Aigner KR, Thiem N (1994) Regional chemotherapy for recurrent breast cancer—the effect of different techniques of drug administration on tumour response. Reg Cancer Treat 7:127–131

    Google Scholar 

  7. Itin AB (1972) Regional intra-arterial chemotherapy of cancer of the pancreas. Khirurgiia (Mosk) 148:22–25

    Google Scholar 

  8. Aigner KR, Müller H, Bassermann R (1990) Intra-arterial chemotherapy with MMC, CDDP and 5-FU for nonresectable pancreatic cancer—a phase II study. Reg Cancer Treat 3:1–6

    Google Scholar 

  9. Gansauge F, Link KH, Rilinger N, Kunz R, Beger HG (1995) Regional chemotherapy in advanced pancreatic carcinoma. Med Klin 90:501–505

    PubMed  Google Scholar 

  10. Link KH, Formentini A, Gansauge F, Papachristov E, Beger HG (1997) Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection. Digestion 58:529–532

    PubMed  Google Scholar 

  11. Link KH, Gansauge F, Pillasch J, Rilinger N, Buchler M, Beger HG (1994) Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion. Dig Surg 11:414–419

    Google Scholar 

  12. Aigner KR, Gailhofer S, Kopp S (1998) Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study. Hepatogastroenterology 45:1125–1129

    PubMed  Google Scholar 

  13. Storniolo AM, Enas NH, Brown CA, Voi M, Rothenberg ML, Schilsky R (1999) An investigational new drug treatment program for patients with gemcitabine: results for over 3,000 patients with pancreatic carcinoma. Cancer 85:1261–1268

    CAS  PubMed  Google Scholar 

  14. Schalhorn A, Kuhl M (1992) Clinical pharmacokinetics of fluorouracil and folinic acid. Semin Oncol 19:82–92

    PubMed  Google Scholar 

  15. Zeller WJ, Zur Hausen H (1995) Onkologie: Grundlagen-Diagnostik-Therapie-Entwicklungen. ecomed.- Losebl. 13[IV-3], 1–4. ecomed.- Losebl.-Ausg. NE, Landsberg/Lech (magazine article)

  16. Gutman M, Abu-Abid S, Sorkine P, Inbar M, Lev D, Chen Z, Oron D, Chaitchik S, Klausner JM (1996) Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer. Cancer 78:1125–1130

    Article  PubMed  Google Scholar 

  17. Shibuya K, Nagata Y, Itoh T, Okajima K, Murata R, Takagi T, Hiraoka M (1999) Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: a feasibility study. Cardiovasc Intervent Radiol 22:196–200

    Google Scholar 

  18. Grosso M, Zanon C, Zanon E, Corsico M, Gazzera C, Mancini A, Fava C (1997) The percutaneous placement of intra-arterial catheters with “reservoirs” for subcutaneous infusion. The technic and preliminary results. Radiol Med (Torino) 94:226–232

    Google Scholar 

  19. Tominaga M, Ku Y, Iwasaki T, Suzuki Y, Kuroda Y, Saitoh Y (1997) Pharmacological evaluation of portal venous isolation and charcoal haemoperfusion for high-dose intra-arterial chemotherapy of the pancreas. Br J Surg 84:1072–1076

    PubMed  Google Scholar 

  20. Homma H, Doi T, Mezawa S (2000) A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer 89:303–313

    Article  PubMed  Google Scholar 

  21. Muchmore JH, Carter RD, Preslan JE, George WJ (1996) Regional chemotherapy with hemofiltration: a rationale for a different treatment approach to advanced pancreatic cancer. Hepatogastroenterology 43:346–355

    PubMed  Google Scholar 

  22. Muchmore JH, Preslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78:664–673

    PubMed  Google Scholar 

  23. Cantore M, Pederzoli P, Cornalba G, Fiorentini G, Guadagni S, Miserocchi L, Frassoldati A, Ceravolo C, Smerieri F, Muchmore JH (2000) Intra-arterial chemotherapy for unresectable pancreatic cancer. Ann Oncol 11:569–573

    Article  PubMed  Google Scholar 

  24. Ohigashi H, Ishikawa O, Imaoka S, Sasaki Y, Kabuto T, Kameyama M, Furukawa H, Hiratuka M, Nakamori S, Nakano H, Yasuda T, Iwanaga T (1996) A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepatogastroenterology 43:338–345

    PubMed  Google Scholar 

  25. Hafstrom L, Ihse I, Jonsson PE, Lunderquist A, Stridbeck H (1980) Intraarterial 5-FU infusion with or without oral testolactone treatment in irresectable pancreatic cancer. Acta Chir Scand 146:445–448

    PubMed  Google Scholar 

  26. Maurer CA, Borner MM, Lauffer J, Friess H, Z’graggen K, Triller J, Buchler MW (1998) Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer. Int J Pancreatol 23:181–186

    PubMed  Google Scholar 

  27. Theodors A, Bukowski RM, Hewlett JS, Livingston RB, Weick JK (1982) Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Am J Clin Oncol 5:555–558

    PubMed  Google Scholar 

  28. Adjei AA, Erlichman C (1999) A phase I trial of MTA and gemcitabine in patients with locally advanced or metastatic cancer. Semin Oncol 26:94–98

    PubMed  Google Scholar 

  29. van Groeningen CJ (1999) Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer. Ann Oncol 10 [Suppl 4]:305–307

    Google Scholar 

  30. Lorenz M, Heinrich S, Staib-Sebler E, Kohne CH, Wils J, Nordlinger B, Encke A (2000) Regional chemotherapy in the treatment of advanced pancreatic cancer—is it relevant? Eur J Cancer 36:957–965

    Article  PubMed  Google Scholar 

  31. Stephens FO (1995) Induction (neo-adjuvant) chemotherapy: systemic and arterial delivery techniques and their clinical applications. Aust N Z J Surg 65:699–707

    PubMed  Google Scholar 

  32. Klapdor R, Seutter E, Lang-Polckow EM, Reichle H, Hinrichs A (1999) Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers. Anticancer Res 19:2459–2469

    PubMed  Google Scholar 

  33. Müller H (1997) Angio-genesis-inhibition and intra-arterial chemotherapy—a new modality treatment for advanced metastatic pancreatic carcinoma. Eur J Cancer 33 [Suppl 8]: 215–215

Download references

Acknowledgments

The authors are grateful to U. Schmidt, Ph.D., Department of Biometrics and Biostatistics, University Hospital, Otto von Guericke University at Magdeburg (Germany) for appropriate statistical advice.

Author information

Authors and Affiliations

  1. Department of Surgery, University Hospital, Otto von Guericke University, Magdeburg, Germany

    Frank Meyer & Hans Lippert

  2. Department of Diagnostic Radiology, University Hospital, Otto von Guericke University, Magdeburg, Germany

    Reinhard Grote

  3. Department of General and Abdominal Surgery, Municipal Hospital, Birkenallee 34, 39130, Magdeburg, Germany

    Karsten Ridwelski

Authors
  1. Frank Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reinhard Grote
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Lippert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karsten Ridwelski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karsten Ridwelski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, F., Grote, R., Lippert, H. et al. Marginal effects of regional intra-arterial chemotherapy as an alternative treatment option in advanced pancreatic carcinoma. Langenbecks Arch Surg 389, 32–39 (2004). https://doi.org/10.1007/s00423-003-0431-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-003-0431-1

Keywords

Search

Navigation